$12 Profit
GNCALong Stock
After good data, which was presented at ASCO (cancer conference) the stock rallied to a high of $11. Afterwards, shares fell and the company did an offering at $3.50. However, insiders so far bought nearly have the offering. The big note here is Glaxo Smith Kline buying a stake. This is a $54M company and GSK is worth $100B. It's a big vote of confidence on the data for GNCA.
| Date | Price | |
|---|---|---|
| Entry | 6/26/2019 | 3.8481 |
| Exit | 6/26/2019 | 3.8601 |
- Total Views95
- Position Size1,000
- Percentage0.31%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
